Description
The FDA has approved a new drug for Alzheimer's. But a lot of experts are skeptical about whether the drug works. Rhitu Chatterjee talks with science correspondent Jon Hamilton about the controversial drug aducanumab and why the U.S. Food and Drug Administration approved it. For more of Jon's reporting, read "For Those Facing Alzheimer's, A Controversial Drug Offers Hope."You can email Short Wave at [email protected] more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy
Audio
Featured in this Episode
No persons identified in this episode.
Transcription
No transcription available yet
Help us prioritize this episode for transcription by upvoting it.
0
upvotes
Popular episodes get transcribed faster